DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology


Modi S, Tsurutani J, Tamura K, Park H, Sagara Y, Murthy R. et al.
Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study.

Cancer Res 2019;
79: P6-17-02

Download Bibliographical Data